Impact of genetic polymorphisms on the pathogenesis of achalasia: An age-dependent paradigm?

Neurogastroenterology and Motility

Volumn 21, Issue 6, 2009, Pages 575-578

  Sarnelli, Giovanni ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Achalasia; Genetic polymorphisms; Nitric oxide; Vasoactive intestinal peptide

Indexed keywords

HLA ANTIGEN CLASS 2; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1;

DISEASE COURSE; ESOPHAGUS ACHALASIA; GENETIC POLYMORPHISM; GROUPS BY AGE; HUMAN; IMMUNE RESPONSE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

AGING; AUTOIMMUNE DISEASES; ESOPHAGEAL ACHALASIA; HUMANS; NEURONS; NITRIC OXIDE; POLYMORPHISM, GENETIC; RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I; VASOACTIVE INTESTINAL PEPTIDE;

EID: 65949103868     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2009.01319.x     Document Type: Review

References (35)

1. Konstantinos NL, Brian DJ. American Gastroenterological Association Future Trends Committee Report: The application of genomic and proteomic technologies to digestive disease diagnosis and treatment and their likely impact on gastroenteroogy clinical practice. Gastroenterology 2005 129 : 1720 52.
2. Tryhus MR, Davis M, Griffith JK et al. Familial achalasia in two siblings: significance of possible hereditary role. J Pediatr Surg 1989 24 : 292 5. (Pubitemid 19070452)
3. Stein DT, Knauer CM. Achalasia in monozygotic twins. Dig Dis Sci 1982 27 : 636 40. (Pubitemid 12075493)
4. De la Concha EG, Fernandez-Arquero M, Mendoza JL et al. Contribution of HLA class II genes to susceptibility in achalasia. Tissue Antigens 1998 52 : 381 4. (Pubitemid 28467013)
5. Verne GN, Hahn AB, Pineau BC et al. Association of HLADR and -DQ alleles with idiopathic achalasia. Gastroenterology 1999 117 : 26 31. (Pubitemid 29297616)
6. Richter JE. Oesophageal motility disorders. Lancet 2001 358 : 823 8. (Pubitemid 32868739)
7. Hirano I, Tatum RP, Shi G et al. Manometric heterogeneity in patients with idiopathic achalasia. Gastroenterology 2001 120 : 789 98.
8. Goldblum JR, Rice TW, Richter JE. Histopathologic features in esophagomyotomy specimens from patients with achalasia. Gastroenterology 1996 111 : 648 54. (Pubitemid 26293229)
9. Clark SB, Rice TW, Tubbs RR et al. The nature of the myenteric infiltrate in achalasia: an immunohistochemical analysis. Am J Surg Pathol 2000 24 : 1153 8. (Pubitemid 30612838)
10. Mearin F, Mourelle M, Guarner F et al. Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction. Eur J Clin Invest 1993 23 : 724 8. (Pubitemid 23349139)
11. Jones DB, Mayberry JF, Rhodes J, Munro J. Preliminary report of an association between measles virus and achalasia. J Clin Pathol 1983 36 : 655 7.
12. Robertson CS, Martin BA, Atkinson M. Varicella-zoster virus DNA in the oesophageal myenteric plexus in achalasia. Gut 1993 34 : 299 302. (Pubitemid 23080251)
13. Castagliuolo I, Brun P, Costantini M et al. Esophageal achalasia: is the herpes simplex virus really innocent? J Gastrointest Surg 2004 8 : 24 30. (Pubitemid 38117274)
14. Birgisson S, Galinski MS, Goldblum JR et al. Achalasia is not associated with measles or known herpes and human papilloma viruses. Dig Dis Sci 1997 42 : 300 6. (Pubitemid 27112974)
15. Boeckxstaens GE. Achalasia: virus-induced euthanasia of neurons? Am J Gastroenterol 2008 103 : 1610 2.
16. Facco M, Brun P, Baesso I et al. T-cells in the myenteric plexus of achalasia patients show a skewed TCR repertoire and react to HSV-1 antigens. Am J Gastroenterol 2008 103 : 1598 609.
17. Calzada JE, López-Nevot MA, Beraún Y et al. No evidence for association of the inducible nitric oxide synthase promoter polymorphism with Trypanosoma cruzi infection. Tissue Antigens 2002 59 : 316 9.
18. Santiago JL, Martinez A, Benito MS et al. Gender-specific association of the PTPN22 C1858 T polymorphism with achalasia. Hum Immunol 2007 68 : 867 70. (Pubitemid 47599718)
19. Tottrup A, Svane D, Forman A. Nitric oxide mediating NANC inhibition in opossum lower esophageal sphincter. Am J Physiol 1991 260 : G385 9.
20. Konturek JW, Thor P, Lukaszyk A et al. Endogenous nitric oxide in the control of esophageal motility in humans. J Physiol Pharmacol 1997 48 : 201 9. (Pubitemid 27305520)
21. Croen KD. Evidence for an antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J Clin Invest 1993 91 : 2446. (Pubitemid 23182495)
22. Karupiah G, Xie Q-w, Buller RML et al. Inhibition of virus replication by interferon-induced nitric oxide synthase. Science 1993 261 : 1445. (Pubitemid 23334265)
23. Mearin F, Garcia-Gonzalez MA, Strunk M et al. Association between achalasia and nitric oxide synthase gene polymorphisms. Am J Gastroenterol 2006 101 : 1979 84. (Pubitemid 44337619)
24. Goyal RK, Rattan S, Said SI. VIP as a possible neurotransmitter of non-cholinergic non-adrenergic inhibitory neurons. Nature 1980 288 : 378 80. (Pubitemid 11169011)
25. Delgado M, Pozo D, Ganea D. The significance of vasoactive intestinal peptide in immunomodulation. Pharmacol Rev 2004 56 : 249 90. (Pubitemid 38720831)
26. Sun W, Hong J, Zang YC et al. Altered expression of vasoactive intestinal peptide receptors in T lymphocytes and aberrant Th1 immunity in multiple sclerosis. Int Immunol 2006 18 : 1691 700.
27. Delgado M, Abad C, Martinez C et al. Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nat Med 2001 7 : 563 8. (Pubitemid 32448323)
28. Delgado M, Robledo G, Rueda B et al. Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: altered expression and signal in immune cells. Arthritis Rheum 2008 58 : 1010 9.
29. Gonzalez-Rey E, Chorny A, Delgado M. Regulation of immune tolerance by anti-inflammatory neuropeptides. Nat Rev Immunol 2007 7 : 52 63. (Pubitemid 46020827)
30. Paladini F, Cocco E, Cascino I et al. Age-dependent association of idiopathic achalasia with vasoactive intestinal peptide receptor 1 gene. Neurogastroenterol Motil 2009 21 : 597 602.
31. Gambaro G, Anglani F, D'Angelo A. Association studies of genetic polymorphisms and complex disease. Lancet 2000 22 : 355(9200) : 308 11. (Pubitemid 30068531)
32. Paladini F, Cocco E, Cauli A et al. A functional polymorphism of the vasoactive intestinal peptide receptor 1 gene correlates with the presence of HLA-B*2705 in Sardinia. Genes Immun 2008 9 : 659 67.
33. Storch WB, Eckardt VF, Wienbeck M et al. Autoantibodies to Auerbach's plexus in achalasia. Cell Mol Biol 1995 41 : 1033 8.
34. Delgado M, Ganea D. Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation. FASEB J 2003 17 : 944 6.
35. Bangale Y, Cavill D, Gordon T et al. Vasoactive intestinal peptide binding autoantibodies in autoimmune humans and mice. Peptides 2002 23 : 2251 7. (Pubitemid 36092061)